Adamis Pharmaceuticals Corp·5

Feb 14, 7:04 PM ET

Glover Eddie Wabern 5

5 · Adamis Pharmaceuticals Corp · Filed Feb 14, 2018

Insider Transaction Report

Form 5
Period: 2017-12-31
Glover Eddie Wabern
CEO of U.S. Compounding, Inc.
Transactions
  • Gift

    Common Stock

    2017-02-1541,666783,334 total
  • Gift

    Common Stock

    2017-11-0241,666783,334 total

Documents

1 file
  • 5
    glover-form5_123117.xmlPrimary

    OWNERSHIP DOCUMENT